MIAMI—November 29, 2022—eMed, the telehealth company that outfits your medicine cabinet with urgent care kits, today announced that Michael Cole was named President and Chief Financial Officer. Cole, who has served as CFO since December 2021, assumed the responsibilities of the President this month.
In his new role as President and Chief Financial Officer of eMed, Michael Cole helps drive the company as it expands into new verticals across the digital health ecosystem and grows its business as a leading digital healthcare platform. He is responsible for leading major operational, financial, and corporate functions, including technology and development, sales and marketing, M&A, corporate finance, treasury, financial planning and analysis, investor relations, accounting, human resources, legal, and corporate administration.
"Michael Cole is a strong executive leader who will continue to evolve and grow eMed as part of our plan to transform healthcare through cost-effective virtual diagnostics and rapid access to treatment," says Dr. Patrice Harris, eMed's Co-Founder and CEO. "He deeply understands eMed's culture, brand, and values. That understanding helps us identify and execute opportunities that move eMed forward."
In an effort to provide immediate at-home testing and treatment options for the healthcare needs of people everywhere, eMed recently unveiled the first-ever COVID-19+Flu Telehealth Kit™. In the upcoming year, eMed is looking to further expand its telehealth services to that of other common acute illnesses.
eMed’s digital healthcare platform:
- Enables rapid diagnostic testing from anywhere with a smart device, the internet, and a smartphone.
- Connects users to an eMed telehealth proctor 24/7, 365 days a year–no appointment necessary.
- Provides digital lab results and diagnostics, made available within minutes of completing the testing process.
- Prescribes rapid access to treatment at no additional cost.
As part of its ongoing commitment to deliver cost-effective, on-demand access to healthcare services, eMed is implementing innovative new technologies to bring virtual care and treatment into the home.
"I am humbled and honored to continue to accelerate eMed's efforts in healthcare and world-class innovation," says Michael Cole, President and Chief Financial Officer. "I look forward to working collaboratively with our leadership team to ensure that eMed continues to grow its stellar reputation as a leader in rapid access to on-demand virtual care and treatment."
Prior to joining eMed, Michael Cole founded SevenSaoi Capital, a private equity investment firm, in 2016. For most of his career, Cole held positions of increasing responsibility with Madison Dearborn Partners, a Chicago-based private equity firm that manages $23B in equity capital. He was a Managing Director of the firm’s Telecom, Media, and Technology Services Team and also worked on healthcare investments. He worked in a senior capacity on Madison Dearborn’s investments in MetroPCS, Intelsat Ltd., XM Satellite Radio, Telemundo, Alaska Native Wireless, The Topps Company, and many others.
Michael Cole was named a “Top 40 Global Dealmaker Under 40” by Dealmaker Magazine, a “Top 40 Under 40” leader by Crain’s Chicago Business, and a Henry Crown Fellow of the Aspen Institute. Cole currently serves on the Boards of Directors of the Big Shoulders Fund and The Lyric Opera of Chicago, for both of which he also serves as a member of the Investment Committee.
eMed is the leader in rapid access to on-demand virtual care and treatment. Our digital healthcare platform outfits your medicine cabinet with an array of telehealth kits for your urgent care needs. It's innovative, efficient, and cost-effective. Learn more at www.eMed.com.